Key Financial Data Of Group

SUSMED, Inc. - Filing #7351363

Concept 2023-07-01 to
2023-12-31
As at
2023-12-31
2023-10-01 to
2023-12-31
As at
2023-06-30
2022-07-01 to
2023-06-30
2022-07-01 to
2022-12-31
As at
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of group
Business results of group
Ordinary profit (loss)
-90,767,000 JPY
-44,318,000 JPY
-187,766,000 JPY
Net assets
4,841,547,000 JPY
4,870,797,000 JPY
4,694,688,000 JPY
Total assets
5,172,011,000 JPY
5,101,124,000 JPY
4,891,214,000 JPY
Basic earnings (loss) per share
-5.49
3.29
-3.09
-11.68
-5.96
Diluted earnings per share
Equity-to-asset ratio
0.933 xbrli:pure
0.953 xbrli:pure
0.959 xbrli:pure
Net cash provided by (used in) operating activities
21,447,000 JPY
100,591,000 JPY
-93,546,000 JPY
Net cash provided by (used in) investing activities
-3,697,000 JPY
-18,189,000 JPY
-14,881,000 JPY
Net cash provided by (used in) financing activities
15,061,000 JPY
62,362,000 JPY
30,058,000 JPY
Cash and cash equivalents
5,081,649,000 JPY
5,048,838,000 JPY
4,825,705,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.